PF

Award-winning Creative & Media Agency Deep Focus Takes Back Its Name Under New Ownership of Bright Mountain Media, Inc. (OTCQB: BMTM)

Retrieved on: 
Wednesday, November 1, 2023

Boca Raton, FL, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Bright Mountain Media, Inc. (OTCQB: BMTM) ("Bright Mountain" or the "Company"), a global holding company with current investments in digital publishing, advertising technology, consumer insights, and creative media services, today announced that Deep Focus, the award-winning creative and media agency most recently known as Big Village Agency, is taking back its name under the new ownership of Bright Mountain Media.

Key Points: 
  • Boca Raton, FL, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Bright Mountain Media, Inc. (OTCQB: BMTM) ("Bright Mountain" or the "Company"), a global holding company with current investments in digital publishing, advertising technology, consumer insights, and creative media services, today announced that Deep Focus, the award-winning creative and media agency most recently known as Big Village Agency, is taking back its name under the new ownership of Bright Mountain Media.
  • This return to its original name represents a refocus on the culture and values that made Deep Focus so successful against all odds over the past two decades.
  • For us, it’s always been Deep Focus, and it feels right to make it official again,” said Matt Steinwald, Deep Focus executive creative director.
  • Deep Focus will continue to be led by Executive Creative Director Matt Steinwald, Managing Director Steve Scutellaro, Head of Strategy Lindsey Allison, and Head of Media & Analytics Kyle Krueger, under Bright Mountain Media CEO Matt Drinkwater.

Pulmonary Fibrosis Foundation and Pulmonary Hypertension Association Provide Guidance on Pulmonary Hypertension Related to Interstitial Lung Disease

Retrieved on: 
Wednesday, October 25, 2023

CHICAGO, Oct. 25, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) and Pulmonary Hypertension Association have developed a position statement that addresses gaps in the screening, diagnosis and treatment of patients living with pulmonary hypertension (PH) related to interstitial lung disease (PH-ILD).

Key Points: 
  • CHICAGO, Oct. 25, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) and Pulmonary Hypertension Association have developed a position statement that addresses gaps in the screening, diagnosis and treatment of patients living with pulmonary hypertension (PH) related to interstitial lung disease (PH-ILD).
  • The PH-ILD position statement, featuring a version for patients and a version for healthcare providers, reflects input from experts in interstitial lung disease (ILD), PH, PH-ILD and patient representatives.
  • More than 250,000 Americans are living with pulmonary fibrosis (PF) and ILD.
  • PF, a form of ILD, can have many causes and they can all be associated with PH.

Pulmonary Fibrosis Foundation Expands Care Center Network for PF Patients

Retrieved on: 
Thursday, October 12, 2023

CHICAGO, Oct. 12, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced that seven medical centers have joined the PFF Care Center Network (CCN) as Clinical Associate members, a new membership option. Each of these Clinical Associates will collaborate with an existing Care Center Network site to help bring the resources of the PFF to even more people living with pulmonary fibrosis (PF) and interstitial lung disease (ILD). The Care Center Network includes 81 CCN sites and seven Clinical Associates in 39 states.

Key Points: 
  • CHICAGO, Oct. 12, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced that seven medical centers have joined the PFF Care Center Network (CCN) as Clinical Associate members, a new membership option.
  • Each of these Clinical Associates will collaborate with an existing Care Center Network site to help bring the resources of the PFF to even more people living with pulmonary fibrosis (PF) and interstitial lung disease (ILD).
  • The newly designated Clinical Associate members of the PFF Care Center Network are:
    Chest Medicine Associates Center for Interstitial Lung Disease (South Portland, ME): Dr. Meagan Moore, Center Director
    Ochsner LSU Health Shreveport – Academic Medical Center (Shreveport, LA): Dr. Prangthip Charoenpong, Center Director
    University of New Mexico (Albuquerque, NM): Dr. Nour Ass'ad, Center Director
    Through the CCN, Care Centers and Clinical Associates collaborate to promote and provide quality care to those living with PF.
  • Each Clinical Associate is paired with a current Care Center member so they may collaborate to expand and improve pulmonary fibrosis care.

PORTABLE, POWERFUL & PREMIUM: NIKON RELEASES THE LIGHTWEIGHT NIKKOR Z 600MM F/6.3 VR S SUPER-TELEPHOTO PRIME

Retrieved on: 
Wednesday, October 11, 2023

MELVILLE, N.Y., Oct. 11, 2023 /PRNewswire/ -- Today Nikon Inc. announced yet another premium super-telephoto lens, the NIKKOR Z 600mm f/6.3 VR S. This latest S-Line prime lens is the newest addition to Nikon's extremely popular lineup of PF lenses that deliver big reach in a surprisingly small and lightweight package.

Key Points: 
  • The NIKKOR Z 600mm f/6.3 VR S is an S-Line super-telephoto prime lens that is made to be easily handheld.
  • With advanced AF and VR performance as well as S-Line superior rendering quality, the NIKKOR Z 600mm f/6.3 VR S gives users the confidence to get tack-sharp images of fast-moving subjects from a distance.
  • The new  NIKKOR Z 600mm f/6.3 VR S will be available in late October for a suggested retail price of $4799.95.
  • * For more information about the latest Nikon products, including the vast collection of NIKKOR Z lenses and the entire line of Z series cameras, please visit Nikonusa.com .

Pulmonary Fibrosis Foundation Announces PFF Summit 2023

Retrieved on: 
Wednesday, September 27, 2023

CHICAGO, Sept. 27, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) will present its biennial PFF Summit 2023 from Nov. 9-11 in Orlando, Fla. The three-day international conference, focused on pulmonary fibrosis (PF) and interstitial lung disease (ILD) research and education, will be held at the JW Marriott Orlando Grande Lakes. The PFF Summit welcomes patients, caregivers, healthcare providers and researchers to discuss the latest information on treatment options and how to live well with PF and ILD.

Key Points: 
  • CHICAGO, Sept. 27, 2023 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) will present its biennial PFF Summit 2023 from Nov. 9-11 in Orlando, Fla.
  • "We are eager to connect patients with one another and with physicians and researchers at the PFF Summit 2023," said Dr. Franck Rahaghi, President, CEO and CMO of the PFF.
  • The PFF Summit 2023 features sessions tailored to each group's experience with PF.
  • The PFF Summit 2023 is made possible by the generous support of Boehringer Ingelheim, the Hales Family Foundation, and other individual and corporate donors.

Wildfire Smoke Provides Stark Reminder of Challenges Faced by Canadian Pulmonary Fibrosis Patients

Retrieved on: 
Monday, September 18, 2023

Many of Canada's 30,000 PF patients who struggle to breathe, can't get the oxygen they need.

Key Points: 
  • Pulmonary fibrosis looms large over the lives of patients and their families, killing more than 3,000 Canadians annually, with more than 14,000 new patients expected to be diagnosed in 2023.
  • Calgary resident Stan Hendriksen explains how excruciating it is for PF patients to breathe every day.
  • More than 30,000 Canadians with pulmonary fibrosis understand and relate to the first-hand accounts of these PF patients.
  • Check out the Canadian Pulmonary Fibrosis Foundation web site or contact [email protected] .

Aequus Reports Second Quarter 2023 Financial Highlights and General Update

Retrieved on: 
Wednesday, August 30, 2023

Net losses decreased by 9.22 % in Second Quarter 2023 compared to the same period last year, with the Second Quarter 2023 net loss of $700,875 versus a $772,100 loss in the three months ended June 30, 2022 (“Second Quarter 2022”).

Key Points: 
  • Net losses decreased by 9.22 % in Second Quarter 2023 compared to the same period last year, with the Second Quarter 2023 net loss of $700,875 versus a $772,100 loss in the three months ended June 30, 2022 (“Second Quarter 2022”).
  • Highlights from the quarter are as follows:
    Sales and marketing costs for Second Quarter 2023 were $372,844 compared to $663,082 in Second Quarter 2022, a decrease of $290,238 or 44%.
  • The Company incurred research and development (“R&D”) expenses of $25,824 in Second Quarter 2023 compared to $7,945 in Second Quarter 2022.
  • General and administration (“G&A”) expenses were $353,584 in Second Quarter 2023 compared to $457,177 in Second Quarter 2022, a decrease of $103,593.

ALASKA GOVERNOR MIKE DUNLEAVY VISITS WHISTLER GOLD-COPPER PROJECT AND U.S. GOLDMINING PROVIDES UPDATE ON PROPOSED ACCESS ROAD

Retrieved on: 
Tuesday, August 8, 2023

ANCHORAGE, Alaska, Aug. 8, 2023 /PRNewswire/ - U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to provide details on Alaska State Governor Mike Dunleavy's recent visit to the Company's Whistler gold-copper project ("Whistler") in Alaska, USA.

Key Points: 
  • ANCHORAGE, Alaska, Aug. 8, 2023 /PRNewswire/ - U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to provide details on Alaska State Governor Mike Dunleavy's recent visit to the Company's Whistler gold-copper project ("Whistler") in Alaska, USA.
  • The Company is also pleased to provide updates on recent significant advancements in Alaska State's 'Roads to Resources' initiative which includes the proposed West Susitna Access Road ("WSAR") to the Whistler project.
  • Alaska State Governor Mike Dunleavy and Alaska Department of Transportation and Public Facilities ("DOT&PF") Commissioner, Ryan Anderson, visited the Company's Whistler Project on August 3, 2023, accompanied by U.S. GoldMining's CEO, Tim Smith.
  • U.S. GoldMining looks forward to working with all governments, agencies and stakeholders as we advance the exciting Whistler gold-copper project".

SIGNA Sports United N.V. Reports H1 FY23 Results

Retrieved on: 
Wednesday, June 28, 2023

Though supply chain pressures eased in H1 FY23, market oversupply and tightening macroeconomic conditions have weakened consumer demand, particularly in non-core markets

Key Points: 
  • Though supply chain pressures eased in H1 FY23, market oversupply and tightening macroeconomic conditions have weakened consumer demand, particularly in non-core markets
    Management announces FY23 guidance to reflect ongoing market dislocation and sustained demand contraction into H2 FY23 before any potential improvement anticipated in FY24.
  • In line with expectations going into FY23, SSU performance has been severely impacted by macroeconomic headwinds and market overstock.
  • Management anticipates a continuation of challenging operating conditions into H2 FY23 with some improvement expected by management in Q4.
  • SSU believes that these non-IFRS measures of financial results (including on a forward-looking basis) provide useful supplemental information to investors about SSU.

Granite Construction Awarded Preconstruction Contract for Parks Hwy MP 319-325 in Alaska

Retrieved on: 
Thursday, May 11, 2023

Granite (NYSE:GVA) has been awarded the preconstruction contract for Parks Highway MP 319-325, the estimated value for construction is $65 million.

Key Points: 
  • Granite (NYSE:GVA) has been awarded the preconstruction contract for Parks Highway MP 319-325, the estimated value for construction is $65 million.
  • The project involves realigning six miles of the existing highway as it traverses a mountain range between Fairbanks and Nenana, Alaska.
  • The project involves realigning six miles of the existing highway as it traverses a mountain range between Fairbanks and Nenana, Alaska.
  • The construction phase is anticipated to begin in the fall of 2025 and finish within the 2027 construction season.